Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy
Abroad (travel likely)RecruitingPHASE2
Conditions
Cerebral Palsy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shirley Ryan AbilityLab, Chicago, Illinois, United States
Study leads
Megan O'Brien, PhD
Principal Investigator
Shirley Ryan AbilityLab